As alarming new data reveals a spike in sudden heart attacks and strokes, the FDA has greenlit Moderna’s latest mRNA COVID shot—no placebo trials, no independent long-term safety data, and post-market studies delayed until 2029 and 2034. Once again, speed trumps caution. Is safety giving way to speed again, or are post-marketing placebo trials a step in the right direction?

AIR DATE: June 5, 2025